A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary ...

Because certain IPF and post-transplant medications can cause sun sensitivity, skin protection is crucial, says columnist Sam Kirton.

Clinical trials are an important part of IPF research, says columnist Sam Kirton, but we need people willing to participate in them.

One of my frustrations as a pulmonary fibrosis patient is finding solid information about what to expect as my PF progresses. I’ve asked several doctors what to expect during the end stage of PF, but ...

These early findings support larger studies of EGCG’s anti-fibrotic potential in IPF, which if confirmed, would place EGCG as a therapy candidate for this patient population. The study, “ Reversal of ...

Secondary efficacy measures included the time to the first occurrence of an acute disease exacerbation, hospitalization due to breathing problems, or death. The trial is also assessing ...

AD-114 is based on shark antibodies, the proteins that help keep sharks healthy. Antibodies are proteins the immune system uses to kill invaders. It has many advantages over traditional monoclonal ...

Patients were assigned randomly to receive either 30 or 60 mg of the therapy, or a placebo, taken twice a day, for about six months. Background use of antifibrotics or select immunosuppressive ...

Esbriet (pirfenidone) is an oral treatment for idiopathic pulmonary fibrosis (IPF) that is known to decrease inflammation by reducing the synthesis of a pro-inflammatory molecule called transforming ...

“Following productive FDA interactions and positive top-line results from the Phase 1b trial, we have designed our RENEW trial to test the promise of our dual mechanism approach to targeting alveolar ...